Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2278-2281

  Nagano, Rie ^a   Shibata, Kaneyoshi ^a   Naito, Tomoyo ^a   Fuse, Aisaku ^a   Asano, Kayo ^a   Hashizume, Terutaka ^a   Nakagawa, Susumu ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 HYDROXYETHYL) 2 [[N (2 HYDROXYETHYL) N METHYLAMINO]THIOCARBONYLTHIO] 1 METHYL 1 CARBAPEN 2 EM 3 CARBOXYLIC ACID; CARBAPENEM DERIVATIVE; CILASTATIN; IMIPENEM; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; DRUG BLOOD LEVEL; ENZYME ACTIVITY; HYDROLYSIS; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SEPTICEMIA; STAPHYLOCOCCUS AUREUS;

EID: 0030773905     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2278     Document Type: Article

References (25)

1. Adachi, Y., K. Nakamura, Y. Kato, N. Hazumi, T. Hashizume, and S. Nakagawa. 1997. In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 41:2282-2285.
2. Campbell, B. J. 1970. Renal dipeptidase. Methods Enzymol. 19:722-729.
3. Chambers, H. F. 1995. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for penicillin-binding protein PBP2a Antimicrob. Agents Chemother. 39:462-466.
4. Farber, B. E., and R. C. Moellering, Jr. 1983. Retrospective study of the toxicity of preparation of vancomycin from 1974 to 1981. Antimicrob. Agents Chemother. 23:138-141.
5. Hajdu, R., K. Hayase, J. Sundelof, K. Hara, H. Kropp, and F. Kahan. 1985. Cilastatin-sensitive lactamase active on carbapenem and penem antibiotics in the lung of rodents, p. 1211-1212. In J. Ishigami (ed.), Recent advantages in chemotherapy. University of Tokyo Press, Tokyo, Japan.
6. Hanaki, H., H. Akagi, M. Yasui, T. Otani, A. Hyodo, and K. Hiramatsu. 1995. TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 39:1120-1126.
7. Hashizume, T., K. Shibata, R. Nagano, Y. Adachi, K. Nakamura, A. Fuse, Y. Kato, N. Hazumi, K. Asano, T. Naito, A. Ishihara, Y. Sawasaki, M. Nishino, M. Uchida, K. Nagami, and K. Samura. 1996. In vitro and in vivo evaluation of BO-3482, a novel dithiocarbamate carbapenem, abstr. F118, p. 120. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Haycock, K. A., J. Roth, and J. Gargon. 1992. Abacus concepts, StatView. Abacus Concepts, Inc., Berkeley, Calif.
9. Johnson, A. P., A. H. C. Uttley, N. Woodford, and R. C. George. 1990. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin. Microbiol. Rev. 3:280-291.
10. Kahan, F. M., H. Kropp, J. G. Sundelof, and J. Birnbaum. 1983. Thienamyein: development of imipenem-cilastatin. J. Antimicrob. Chemother. 12 (Suppl. D):1-35.
11. Kropp, H., J. G. Sundelof, R. Hajdu, and F. M. Kahan. 1982. Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase-I. Antimicrob. Agents Chemother. 22:62-70.
12. Levine, D. P., B. S. Fromm, and B. R. Reddy. 1991. Slow response to vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674-680.
13. Lyon, B. R., and R. Skurray. 1987. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol. Rev. 51:88-134.
14. 50 and its error by means of logarithmic-probit graph paper. Proc. Soc. Exp. Biol. Med. 57:261-264.
15. Nakashima, M., K. Katagiri, and T. Oguma. 1992. Phase I studies on vancomycin hydrochloride for injection. Chemotherapy (Tokyo) 40:210-224.
16. Noble, W. C., Z. Virani, and R. G. A. Gee. 1992. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 93:195-198.
17. O'Callaghan, C. H., A. Morris, S. M. Kirby, and A. H. Shinglar. 1972. Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288.
18. Oshida, T., T. Onta, N. Nakanishi, T. Matsushita, and T. Yamaguchi. 1990. Activity of sub-minimal inhibitory concentrations of aspoxicillin in prolonging the postantibiotic effect against Staphylococcus aureus. J. Antimicrob. Chemother. 26:29-38.
19. Saravolatz, D. L., D. J. Pohlod, and L. M. Arking. 1982. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann. Intern. Med. 97:325-329.
20. Schwalbe, R. S., J. T. Stapleton, and P. H. Gilligan. 1987. Emergence of vancomycin resistance in coagulase negative staphylococci. N. Engl. J. Med. 316:157-161.
21. Sumita, Y., H. Nouda, K. Kanazawa, and M. Fukasawa. 1995. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 39:910-916.
22. Tsubouchi, H., and H. Ishikawa. 1995. Synthesis and biological properties of a series of optically active 2-oxaisocephems. Bioorg. Med. Chem. 3:143-150.
23. Wise, R., J. M. Andrews, and D. Thornber. 1994. The in-vitro activity of FK-037, a new broad spectrum injectable cephalosporin. J. Antimicrob. Chemother. 34:629-637.
24. Woodford, N., A. P. Jhonson, D. Morrison, and D. C. E. Speller. 1995. Current perspectives on glycopeptide resistance. Clin. Microbiol. Rev. 8:585-615.
25. Yamaoka, K., T. Nakagawa, and T. Uno. 1978. Statistical moment in pharmacokinetics. J. Pharmacokinet. Biopharm. Pharmacol. 30:476-478.